Alex Secora

971 total citations
19 papers, 472 citations indexed

About

Alex Secora is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Alex Secora has authored 19 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Epidemiology. Recurrent topics in Alex Secora's work include Opioid Use Disorder Treatment (7 papers), Substance Abuse Treatment and Outcomes (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Alex Secora is often cited by papers focused on Opioid Use Disorder Treatment (7 papers), Substance Abuse Treatment and Outcomes (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Alex Secora collaborates with scholars based in United States, Australia and Switzerland. Alex Secora's co-authors include Josef Coresh, Morgan E. Grams, G. Caleb Alexander, Jung‐Im Shin, Alex R. Chang, Lesley A. Inker, Yingying Sang, Judy A. Staffa, Shoshana H. Ballew and Aozhou Wu and has published in prestigious journals such as Circulation, Mayo Clinic Proceedings and JAMA Internal Medicine.

In The Last Decade

Alex Secora

18 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex Secora United States 10 112 104 91 68 61 19 472
Taco B. M. Monster Netherlands 8 76 0.7× 116 1.1× 60 0.7× 18 0.3× 38 0.6× 14 438
Adnan Al Shaikh Saudi Arabia 17 181 1.6× 29 0.3× 61 0.7× 69 1.0× 89 1.5× 41 615
Jennifer Donnan Canada 15 239 2.1× 31 0.3× 72 0.8× 124 1.8× 68 1.1× 44 714
Katherine E. Di Palo United States 12 54 0.5× 344 3.3× 46 0.5× 58 0.9× 57 0.9× 23 634
Michele Tari Italy 13 54 0.5× 59 0.6× 34 0.4× 25 0.4× 59 1.0× 26 615
Mireia Puig Spain 15 33 0.3× 174 1.7× 37 0.4× 76 1.1× 56 0.9× 79 625
Nivethika Jeyakumar Canada 13 74 0.7× 32 0.3× 36 0.4× 33 0.5× 17 0.3× 32 405
Allan Ellsworth United States 12 127 1.1× 138 1.3× 163 1.8× 46 0.7× 126 2.1× 26 703
P Fender France 11 99 0.9× 51 0.5× 35 0.4× 14 0.2× 29 0.5× 35 378
R. Lewanczuk Canada 12 89 0.8× 91 0.9× 129 1.4× 43 0.6× 68 1.1× 19 417

Countries citing papers authored by Alex Secora

Since Specialization
Citations

This map shows the geographic impact of Alex Secora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Secora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Secora more than expected).

Fields of papers citing papers by Alex Secora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Secora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Secora. The network helps show where Alex Secora may publish in the future.

Co-authorship network of co-authors of Alex Secora

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Secora. A scholar is included among the top collaborators of Alex Secora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Secora. Alex Secora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Karami, Sara, Adebola Ajao, Jennie Wong, et al.. (2023). The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths. Pharmacoepidemiology and Drug Safety. 32(7). 735–751. 1 indexed citations
3.
Reynolds, Matthew W., et al.. (2022). Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case–control design. Journal of Comparative Effectiveness Research. 11(16). 1161–1172. 5 indexed citations
4.
Becker, William C., Robert Heimer, Catherine M. Dormitzer, et al.. (2021). Merging statewide data in a public/university collaboration to address opioid use disorder and overdose. Addiction Science & Clinical Practice. 16(1). 1–1. 9 indexed citations
5.
Secora, Alex, Jung‐Im Shin, Yao Qiao, et al.. (2020). Hyperkalemia and Acute Kidney Injury with Spironolactone Use Among Patients with Heart Failure. Mayo Clinic Proceedings. 95(11). 2408–2419. 20 indexed citations
6.
Qiao, Yao, Jung‐Im Shin, Yingying Sang, et al.. (2019). Discontinuation of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Mayo Clinic Proceedings. 94(11). 2220–2229. 48 indexed citations
7.
Zonozi, Reza, Aozhou Wu, Jung‐Im Shin, et al.. (2019). Elevated Vancomycin Trough Levels in a Tertiary Health System: Frequency, Risk Factors, and Prognosis. Mayo Clinic Proceedings. 94(1). 17–26. 15 indexed citations
8.
Secora, Alex, G. Caleb Alexander, Shoshana H. Ballew, Josef Coresh, & Morgan E. Grams. (2018). Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults. Value in Health. 21. S266–S266. 7 indexed citations
9.
Shin, Jung‐Im, Alex Secora, G. Caleb Alexander, et al.. (2018). Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation. Clinical Journal of the American Society of Nephrology. 13(8). 1144–1152. 51 indexed citations
10.
Secora, Alex, G. Caleb Alexander, Shoshana H. Ballew, Josef Coresh, & Morgan E. Grams. (2018). Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults. Drugs & Aging. 35(8). 735–750. 58 indexed citations
11.
Lazarus, Benjamin, Aozhou Wu, Jung‐Im Shin, et al.. (2018). Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function. JAMA Internal Medicine. 178(7). 903–903. 116 indexed citations
12.
Secora, Alex, et al.. (2017). Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review. Pharmacoepidemiology and Drug Safety. 27(5). 464–472. 46 indexed citations
13.
By, Kunthel, Jana McAninch, Alex Secora, et al.. (2017). Important statistical considerations in the evaluation of post‐market studies to assess whether opioids with abuse‐deterrent properties result in reduced abuse in the community. Pharmacoepidemiology and Drug Safety. 27(5). 473–478. 9 indexed citations
14.
Shin, Jung‐Im, Alex Secora, Josef Coresh, Alex R. Chang, & Morgan E. Grams. (2017). Abstract P255: Use of Novel Oral Anticoagulants Among Patients With Atrial Fibrillation Increased Even in Those With Severely Impaired Kidney Function. Circulation. 135(suppl_1). 1 indexed citations
15.
Secora, Alex, et al.. (2016). Drug availability adjustments in population-based studies of prescription opioid abuse. Pharmacoepidemiology and Drug Safety. 26(2). 180–191. 8 indexed citations
16.
Secora, Alex, Catherine M. Dormitzer, Judy A. Staffa, & Gerald J. Dal Pan. (2014). Measures to quantify the abuse of prescription opioids: a review of data sources and metrics. Pharmacoepidemiology and Drug Safety. 23(12). 1227–1237. 32 indexed citations
17.
Secora, Alex, et al.. (2014). Drug Availability Adjustments in Population-Based Studies of Prescription Opioid Abuse. Annals of Epidemiology. 24(9). 694–694. 2 indexed citations
18.
Secora, Alex, et al.. (2010). A Comparison of Psychosocial and Cognitive Functioning Between Depressed and Non-Depressed Patients with Cannabis Dependence. Journal of Addictive Diseases. 29(3). 325–337. 9 indexed citations
19.
Levin, Frances R., John J. Mariani, Alex Secora, et al.. (2009). Atomoxetine Treatment for Cocaine Abuse and Adult Attention Deficit/Hyperactivity Disorder (ADHD): A Preliminary Open Trial. Journal of Dual Diagnosis. 5(1). 41–56. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taco B. M. Monster Breakdown of academic impact, for papers by Adnan Al Shaikh Breakdown of academic impact, for papers by Jennifer Donnan Breakdown of academic impact, for papers by Katherine E. Di Palo Breakdown of academic impact, for papers by Michele Tari Breakdown of academic impact, for papers by Mireia Puig Breakdown of academic impact, for papers by Nivethika Jeyakumar Breakdown of academic impact, for papers by Allan Ellsworth Breakdown of academic impact, for papers by P Fender Breakdown of academic impact, for papers by R. Lewanczuk
Rankless by CCL
2026